Results 241 to 250 of about 292,285 (303)
Second primary cancers following hematologic malignancies: Epidemiology, pathobiology and clinical management. [PDF]
Pan Y, Yang H, Shao J, Qiang X, Wang Q.
europepmc +1 more source
ABSTRACT Hepatocellular carcinoma (HCC) remains a significant clinical challenge due to the limited efficacy of conventional treatments like surgery, radiofrequency ablation (RFA), and transarterial embolization (TAE). Here, we develop an innovative TAE and immunothermal therapy strategy based on smartly assembled near‐micron layered double hydroxide ...
Qitao Hu +12 more
wiley +1 more source
Engineering Stem Cells for Islet Replacement Therapy: Recent Advances and Barriers for Clinical Translation. [PDF]
Kuncha J +6 more
europepmc +1 more source
Pyroptosis‐Inducing Engineered Microparticles for Cancer Immunotherapy
Engineered microparticles co‐delivering geldanamycin and dual nanobodies induce targeted pyroptosis and block PD‐L1 and CD47 pathways, reprogramming the tumor microenvironment and achieving potent antitumor immunity in lung cancer models with minimal toxicity.
Tianli Hao +12 more
wiley +1 more source
Clinical management of cancer after kidney transplantation. [PDF]
Hiramitsu T +8 more
europepmc +1 more source
Management of Severe Behçet's Disease. [PDF]
Abacar K, Direskeneli H, Alibaz-Oner F.
europepmc +1 more source
Bilateral Eales' Disease Managed With Vitrectomy and Anti-VEGF Therapy: A Case Report. [PDF]
Lelek Z +7 more
europepmc +1 more source
Viral hepatitis after liver transplantation: A brief overview. [PDF]
Praharaj DL +8 more
europepmc +1 more source
Weaning of immunosuppression in long-term recipients of living related renal transplants: A preliminary study [PDF]
Fung, JJ +5 more
core

